Merck seeks to halt Actavis from marketing generic version of NuvaRing
An article published by Bloomberg News on December 24 reported that drug maker Merck sued Actavis’ subsidiary Warner Chilcott in a federal court in Delaware over allegations that it attempted to sell a generic form of Merck’s NuvaRing bef…
Read MoreWritten by James H. Arenson
Last Updated : January 2, 2014